Related Experiment Video
Updated: Sep 13, 2025
Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
Published on: November 1, 2024
Should CBD be used for migraine?
Brent Luu1, Philippe Goldin, Elizabeth Rice
1At the Betty Irene Moore School of Nursing at UC Davis in Sacramento, CA, Brent Luu is a clinical professor, Philippe Goldin is a professor, and Elizabeth Rice is a clinical professor. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Migraine affects millions globally, causing significant disability and lost productivity. This review examines cannabidiol (CBD) as a potential treatment for migraine prevention and relief.
Area of Science:
- Neurology
- Pharmacology
Background:
- Migraine is a prevalent neurological disorder affecting 12% of the US population and 1.1 billion globally.
- It is a leading cause of disability worldwide, particularly impacting women aged 15-49.
- Migraine significantly disrupts work, financial stability, personal relationships, and overall well-being.
Purpose of the Study:
- To provide an updated review of clinical evidence for cannabidiol (CBD) in migraine management.
- To assess CBD's efficacy as an adjunct or alternative to existing migraine treatments.
Main Methods:
- Review of existing clinical studies and evidence.
- Analysis of research on cannabidiol's role in migraine prevention and acute treatment.
Main Results:
- Evidence suggests potential benefits of cannabidiol for migraine.
- Further research is needed to establish optimal dosing and long-term efficacy.
Conclusions:
- Cannabidiol shows promise as a therapeutic option for migraine.
- Clinicians should consider CBD as part of a comprehensive migraine management strategy.
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids